Related Experiment Video
Updated: Jun 2, 2025

12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
27.8K
Exploring the Relationship Between Sleep Apnea, Myocardial Infarct Size, and Coronary Collaterals in Acute Myocardial
Vaishnavi Kundel1, Kavya Devarakonda1, Samira Khan1
1Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nature and Science of Sleep
|January 16, 2025
Summary
This study explored sleep apnea's role in acute myocardial infarction (AMI) patients. Moderate sleep apnea (SA) showed a trend toward smaller infarct size and better coronary collaterals, suggesting potential cardioprotective benefits.
Area of Science:
- Cardiology
- Sleep Medicine
- Medical Imaging
Background:
- Sleep apnea (SA) is a common condition that affects cardiovascular health.
- Acute myocardial infarction (AMI) is a leading cause of mortality worldwide.
- The cardioprotective role of SA in AMI patients remains unclear.
Purpose of the Study:
- To investigate the association between sleep apnea severity and infarct size in patients with acute myocardial infarction (AMI).
- To examine the relationship between sleep apnea and coronary collateral circulation in AMI patients.
- To explore the potential cardioprotective role of sleep apnea in the context of AMI.
Main Methods:
- Recruited adult patients with AMI who underwent sleep apnea (SA) testing and cardiac magnetic resonance (CMR) imaging.
- Quantified infarct size using delayed-enhancement CMR and coronary collateralization using the Rentrop Score.
- Compared infarct size and Rentrop grade across different SA severities using statistical tests (Wilcoxon Rank-Sum, Fisher's Exact).
Main Results:
- Of 33 patients, 76% had SA (mild, moderate, severe).
- No statistically significant differences in median infarct size were found between no SA (22%) and SA groups (28%).
- Moderate SA showed a trend toward smaller infarct size (15.5%) and a higher proportion of augmented coronary collaterals (62.5%) compared to other groups.
Conclusions:
- The study found no statistically significant differences in infarct size or coronary collaterals based on SA severity in AMI patients.
- Results suggest a potential cardioprotective benefit of moderate SA, warranting further investigation.
- Future research should explore SA's heterogeneous effects on ischemic preconditioning to guide clinical management in AMI patients.

